Just as well that Second Sight’s retinal prosthesis Argus II is already on sale in Western markets as a therapy for blindness. The first human data on its follow-up system, Orion, designed to widen the treatable population, are somewhat lukewarm.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,